Meta Faces Landmark Trial; Peptides for Pets

Meta faces a landmark federal trial brought by 29 states over allegations that Facebook and Instagram were deliberately designed to addict young users and that the company improperly collected children’s data. The case could expose Meta to substantial penalties and potentially more consequential court-ordered changes to how its platforms operate.

Also this weekend, pet owners are spending money on experimental treatments they believe will help their pets live better and longer lives, including peptide injections, red-light therapy, and nutritional supplements. Some pet owners are giving their pets rapamycin, a drug that has shown promising anti-aging properties in studies with mice, despite the lack of official results on its effectiveness in dogs and cats.

On today’s show, Lisa Mateo, Joe Mathieu, and Carol Massar speak with:

- California Attorney General Rob Bonta, on how the landmark youth safety case against Meta is a “tobacco moment.”

- Anna Edney, Bloomberg News National Health Care Reporter, on the pet owners spending big on anti-aging drugs and peptides.

- Amanda Mull, Bloomberg Businessweek Senior Reporter, on the backlash against influencers who seek to achieve physical perfection.

- Olivia Ferney, Luxury Travel & Event Expert, on planning events for a roster of ultra-wealthy clients.

For more conversations like this, watch and listen to Bloomberg This Weekend live on Saturdays and Sundays from 7AM-10AM ET. Watch on Bloomberg Television, listen on Bloomberg Radio and stream the show live on the Bloomberg Business app and Bloomberg.com/video.

See omnystudio.com/listener for privacy information.